SUPREN
Active substance: ARSENIC TRIOXIDE, SULFURIC ACID, CHAMAELIRIUM LUTEUM ROOT, GOLDENSEAL, WOOD CREOSOTE, LEMNA MINOR WHOLE, MAGNESIUM FLUORIDE, SILICON DIOXIDE
SOLUTION/ DROPS · ARSENIC TRIOXIDE 12 [hp_X]/100mL, SULFURIC ACID 8 [hp_X]/100mL, CHAMAELIRIUM LUTEUM ROOT 12 [hp_X]/100mL, GOLDENSEAL 12 [hp_X]/100mL, WOOD CREOSOTE 12 [hp_X]/100mL, LEMNA MINOR WHOLE 12 [hp_X]/100mL, MAGNESIUM FLUORIDE 12 [hp_X]/100mL, SILICON DIOXIDE 12 [hp_X]/100mL
United StatesActive
Marketing holder: PEKANA Naturheilmittel GmbH
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ARSENIC TRIOXIDE · 12 [hp_X]/100mL
- SULFURIC ACID · 8 [hp_X]/100mL
- CHAMAELIRIUM LUTEUM ROOT · 12 [hp_X]/100mL
- GOLDENSEAL · 12 [hp_X]/100mL
- WOOD CREOSOTE · 12 [hp_X]/100mL
- LEMNA MINOR WHOLE · 12 [hp_X]/100mL
- MAGNESIUM FLUORIDE · 12 [hp_X]/100mL
- SILICON DIOXIDE · 12 [hp_X]/100mL
Products containing arsenic trioxide in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| EU 4 |
|
Registration
- Registration number
- 59469-060
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 59469-060 · Verified 2026-10-09 · open in source